![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Lighthouse Lab Services’ COVID-19 Test Gets Emergency Use Authorization
Lighthouse Lab Services’ COVID-19 Test Gets Emergency Use Authorization
LMSI, which does business as Lighthouse Lab Services, has received the FDA’s Emergency Use Authorization for its CovidNow SARS-CoV-2 assay.
The COVID-19 test is authorized for use with nasopharyngeal, oropharyngeal or nasal samples. It is also authorized for use with the company’s CovidNow Collection Kit with nasal swab samples that are self-collected at home or in a community-based setting by people age 18 and up who have suspected COVID-19 and have been referred by a healthcare provider.
Sample analysis must be done by authorized laboratories designated by Lighthouse Lab Services and certified under the Clinical Laboratory Improvement Amendments of 1988.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct